Glass Jacobson Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.73K Hold
144
﹤0.01% 469
2025
Q4
$7.77K Hold
144
﹤0.01% 465
2025
Q3
$6.5K Hold
144
﹤0.01% 475
2025
Q2
$6.67K Sell
144
-366
-72% -$18K ﹤0.01% 457
2025
Q1
$28.8K Hold
510
0.01% 458
2024
Q4
$28.8K Sell
510
-201
-28% -$11.2K 0.01% 458
2024
Q3
$36.8K Sell
711
-4
-0.6% -$188 0.01% 410
2024
Q2
$29.7K Hold
715
0.01% 423
2024
Q1
$38.8K Hold
715
0.01% 384
2023
Q4
$36.7K Hold
715
0.02% 369
2023
Q3
$41.5K Hold
715
0.02% 338
2023
Q2
$45.7K Buy
+715
New +$47.9K 0.02% 338
2022
Q4
$55K Buy
+765
New +$57.7K 0.03% 332

Other funds holding BMY

Glass Jacobson Investment Advisors's BMY Position: Q1 2026 in Review

Glass Jacobson Investment Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 144 shares worth $8.73K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

Glass Jacobson Investment Advisors first reported a position in BMY in Q4 2022 and has held it in 13 quarters since. The position peaked at $55K in Q4 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Glass Jacobson Investment Advisors held 144 shares of Bristol-Myers Squibb worth $8.73K as of Q1 2026.
  • Glass Jacobson Investment Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Glass Jacobson Investment Advisors's portfolio in Q1 2026, its #469 holding.
  • Glass Jacobson Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 13 quarters since.
  • Glass Jacobson Investment Advisors's Bristol-Myers Squibb position peaked at $55K in Q4 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.